secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K
Filed at:   2026-01-07T23:59:59+00:00
Accession:  0001104659-26-001825
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Praxis Precision Medicines prices $661M equity offering at $260/share, net proceeds ~$621M
--------------------------------------------------------------------------------

- Offering of 2,212,000 shares plus full exercise of underwriter option for 331,800 shares at $260/share.
- Net proceeds estimated at $621.2M after underwriting discounts and expenses.
- Underwriters: Piper Sandler, TD Securities, Guggenheim Securities; closing expected Jan 8, 2026.
- Proceeds to fund commercialization prep, R&D, and working capital; cash runway extended into 2028.
- Offering made under effective shelf registration (Form S-3 ASR filed Dec 23, 2024).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000110465926001825/0001104659-26-001825-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000110465926001825/tm261686d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-001825

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer